High expression of VASP cloud be combined with some classic tumor markers (such as prostate-specific antigen, carcinoembryonic antigen, alpha-fetoprotein, etc.) to evaluate the prognosis of patients. This evidence concerns the gene CEACAM5 and neoplasm.